LIVE WEBINAR
June 21st | 10am EST | 6pm GST
Addressing Food Allergy Prevention and Recently Approved Treatment
Join Dr. Deepa Grandon and Dr. Inmaculada Cerecedo, MD as they explore the recent approval of Omalizumab as a safe treatment option for food allergies.
What will we be covering?
- Uncover the science behind IgE-mediated food reactions and how Omalizumab effectively targets this pathway
- Discover the evidence supporting Omalizumab's safety and efficacy in treating multiple food allergies
- Learn the age-appropriate considerations for Omalizumab treatment and acquire crucial insights into necessary precautions for optimal patient care
- Explore the implications of the FDA's approval of Omalizumab for patients and healthcare providers
- Gain the knowledge to confidently discuss and make informed decisions about Omalizumab treatment
Join us on June 21st, 10 am EST | 6pm GST to learn all about:
Addressing Food Allergy Prevention and Recently Approved Treatment
Meet your speakers:
Learn From Renowned Physicians
Dr. Deepa Grandon MD, MBA
A triple board-certified physician with 23 years of experience, Dr. Grandon is a Diplomat of the American Board of Internal Medicine, American Board of Allergy and Immunology and American Board of Lifestyle Medicine. As the founder and CEO of Transformational Life Consultancy, she focuses on preventive strategies for chronic lifestyle disease-complicated allergy/immunology conditions.
Dr. Inmaculada Cerecedo, MD
Dr. Inmaculada Cerecedo, MD, is a Board Certified Allergist with special expertise in Food Allergy prevention and treatment. She received her medical degree from Universidad de Cantabria in Santander, Spain, and completed her residency at Hospital Universitario Ramon y Cajal in Madrid, Spain, and The Jaffe Food Allergy Institute at the Icahn School of Medicine at Mount Sinai, New York, US. Dr. Cerecedo has been actively involved in multiple research projects in the field of food allergy, focusing on epitope mapping, socioeconomic impact, and quality of life in patients with food allergy. Currently, she is investigating early interventions to prevent and manage food allergies in babies and children. Dr. Cerecedo resides in Abu Dhabi with her family and enjoys traveling, going to the beach, and hiking in her free time.
Join us LIVE to explore the recently approved FDA indication of Omalizumab for multiple food allergies, and empower high-risk families with proven preclusion strategies.
By registering, you secure your spot for our live event. By upgrading to VIP you gain exclusive access to the event recording for 2 weeks.